NCT03154294
- Conditions
- Advanced Solid Tumor
- Locations
-
- Avera Cancer Institute Sioux Falls, South Dakota, United States
Clinical trial condition
Advanced Solid Tumor
Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.
514 public trials
240 recruiting studies
Advanced Solid Tumor trial results
NCT04675528
- Conditions
- Advanced Solid Tumor
- Locations
-
- University of Semmelweis, 1st Internal Medicine Clinic, Department of Clinical Pharmacology Budapest, Hungary
- National Institute of Oncology Budapest, Hungary
- University of Debrecen-Clinical Center, Internal Medicine Clinic, Department of Clinical Pharmacology Debrecen, Hungary
- Clinexpert Ltd Phase I. Studycenter Gyöngyös, Hungary
Completed
First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors
NCT04505839
- Conditions
- Advanced Solid Tumor
- Locations
-
- University of Southern California Los Angeles, California, United States
- University of Colorado Denver Denver, Colorado, United States
- Northwestern University Evanston, Illinois, United States
NCT05594875
- Conditions
- Advanced Solid Tumor
- Locations
-
- Scientia Clinical Research Sydney, New South Wales, Australia
- Macquarie Hospital Sydney, New South Wales, Australia
- Sydney South West Private Hospital Sydney, New South Wales, Australia
- ICON Cancer Centre Brisbane, Queensland, Australia
NCT04638491
- Conditions
- Advanced Solid Tumor
- Locations
-
- Jilin Provincial Tumor Hospital Changchun, Jilin, China
NCT04336098
- Conditions
- Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +15 more
- Locations
-
- City of Hope Duarte, California, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- University of Colorado Aurora, Colorado, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Conditions
- Advanced Solid Tumor, Carcinoma, Carcinoma, Squamous Cell, +8 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- Yale University School of Medicine New Haven, Connecticut, United States
- University of Chicago Hospitals Chicago, Illinois, United States
- Henry Ford Health System Detroit, Michigan, United States
Completed
Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors
NCT05508100
- Conditions
- Advanced Solid Tumor
- Locations
-
- The First Affiliated Hospital of Fujian Medical University Fujian, Fuzhou, China
- 1st affiliated Hospital of Hainan Medical University Haikou, Hainan, China
- 4th Hospitla of Hebei Medical University Shijiazhuang, Hebei, China
- Harbin Cancer Hospital Harbin, Heilongjiang, China
Completed
PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
NCT04887194
- Conditions
- Advanced Solid Tumor
- Locations
-
- Goshen Health Goshen, Indiana, United States
- NEXT Oncology Austin, Texas, United States
- NEXT Oncology San Antonio, Texas, United States
- NEXT Oncology Fairfax, Virginia, United States
NCT03874897
- Conditions
- Advanced Solid Tumor
- Locations
-
- Department of GI Oncology, Peking University Cancer Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
- The First Affiliated Hospital , Zhejiang University School of Medicine Hangzhou, Zhejiang, China